Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Gains from Investment Securities (2016 - 2019)

Historic Gains from Investment Securities for Wave Life Sciences (WVE) over the last 5 years, with Q3 2019 value amounting to $2.6 million.

  • Wave Life Sciences' Gains from Investment Securities rose 2551000.0% to $2.6 million in Q3 2019 from the same period last year, while for Dec 2022 it was $4.9 million, marking a year-over-year change of. This contributed to the annual value of $12.0 million for FY2022, which is 16691.86% up from last year.
  • As of Q3 2019, Wave Life Sciences' Gains from Investment Securities stood at $2.6 million, which was up 2551000.0% from $2.3 million recorded in Q2 2019.
  • In the past 5 years, Wave Life Sciences' Gains from Investment Securities ranged from a high of $3.2 million in Q2 2016 and a low of -$416000.0 during Q4 2017
  • Over the past 5 years, Wave Life Sciences' median Gains from Investment Securities value was $182000.0 (recorded in 2017), while the average stood at $1.0 million.
  • Per our database at Business Quant, Wave Life Sciences' Gains from Investment Securities tumbled by 18303.39% in 2017 and then soared by 2551000.0% in 2019.
  • Wave Life Sciences' Gains from Investment Securities (Quarter) stood at $2.7 million in 2015, then tumbled by 81.15% to $501000.0 in 2016, then tumbled by 183.03% to -$416000.0 in 2017, then soared by 102.4% to $10000.0 in 2018, then skyrocketed by 25510.0% to $2.6 million in 2019.
  • Its last three reported values are $2.6 million in Q3 2019, $2.3 million for Q2 2019, and $2.6 million during Q1 2019.